Regent Peak Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Buy
1,729
+37
+2% +$12.7K 0.12% 82
2026
Q1
$595K Buy
1,692
+7
+0.4% +$2.5K 0.12% 74
2025
Q4
$552K Sell
1,685
-224
-12% -$71.1K 0.11% 83
2025
Q3
$539K Buy
+1,909
New +$554K 0.11% 84
2025
Q1
$686K Sell
2,201
-589
-21% -$174K 0.16% 63
2024
Q4
$727K Sell
2,790
-5,525
-66% -$1.64M 0.16% 64
2024
Q3
$2.68M Sell
8,315
-713
-8% -$233K 0.62% 31
2024
Q2
$2.82M Buy
9,028
+542
+6% +$159K 0.65% 33
2024
Q1
$2.41M Sell
8,486
-1,153
-12% -$337K 0.61% 40
2023
Q4
$2.78M Sell
9,639
-178
-2% -$48.5K 0.75% 33
2023
Q3
$2.64M Sell
9,817
-23
-0.2% -$5.74K 0.81% 26
2023
Q2
$2.18M Buy
9,840
+102
+1% +$23.7K 0.64% 41
2023
Q1
$2.35M Sell
9,738
-447
-4% -$110K 0.73% 36
2022
Q4
$2.67M Buy
10,185
+365
+4% +$97.8K 0.88% 24
2022
Q3
$2.21M Buy
9,820
+145
+1% +$35.1K 0.78% 27
2022
Q2
$2.35M Buy
9,675
+280
+3% +$68.6K 0.77% 31
2022
Q1
$2.27M Buy
9,395
+1,141
+14% +$262K 0.65% 36
2021
Q4
$1.86M Buy
8,254
+6,400
+345% +$1.35M 0.5% 45
2021
Q3
$394K Sell
1,854
-191
-9% -$44K 0.11% 106
2021
Q2
$494K Sell
2,045
-5,955
-74% -$1.46M 0.14% 90
2021
Q1
$1.99M Buy
8,000
+1,121
+16% +$267K 0.65% 34
2020
Q4
$1.58M Buy
6,879
+283
+4% +$65.2K 0.53% 41
2020
Q3
$1.68M Buy
6,596
+422
+7% +$105K 0.71% 31
2020
Q2
$1.46M Buy
6,174
+65
+1% +$14.8K 0.66% 33
2020
Q1
$1.24M Buy
6,109
+220
+4% +$48.1K 0.69% 31
2019
Q4
$1.42M Buy
+5,889
New +$1.3M 0.65% 28

Other funds holding AMGN

Regent Peak Wealth Advisors's AMGN Position: Q2 2026 in Review

Regent Peak Wealth Advisors increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $12.7K and bringing the position to 1,729 shares worth $626K. The position accounts for 0.12% of the portfolio, ranked #82.

Regent Peak Wealth Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.82M in Q2 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Regent Peak Wealth Advisors held 1,729 shares of Amgen worth $626K as of Q2 2026.
  • Regent Peak Wealth Advisors bought 37 Amgen shares in Q2 2026, an estimated $12.7K.
  • Amgen made up 0.12% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #82 holding.
  • Regent Peak Wealth Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • Regent Peak Wealth Advisors's Amgen position peaked at $2.82M in Q2 2024.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.